Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer
Clinical trial NCT03892655 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03892655
- Sponsor
- Libbs Farmacêutica LTDA
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-07
- Primary completion
- 2022-12-30
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.